Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions (original) (raw)
Experimental Identification of Immuno- dominant B-cell Epitopes from SARS-CoV-2
Pierre Daguer
CHIMIA International Journal for Chemistry, 2021
View PDFchevron_right
Evolution of Antibody Immunity to SARS-CoV-2
Michael Tankelevich
View PDFchevron_right
The Antibody Response to SARS-CoV-2 Infection
Linda Hueston
Open Forum Infectious Diseases, 2020
View PDFchevron_right
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions
Naveenchandra Suryadevara
View PDFchevron_right
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
jia jan
2020
View PDFchevron_right
Simultaneous detection of antibody responses to multiple SARS-CoV-2 antigens by a Western blot serological assay
Jen-Ren Wang
Applied Microbiology and Biotechnology
View PDFchevron_right
Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus
Xin-Yong Yuan, Jody D Berry
Molecular immunology, 2005
View PDFchevron_right
Profiles of Antibody Responses against Severe Acute Respiratory Syndrome Coronavirus Recombinant Proteins and Their Potential Use as Diagnostic Markers
Chih-Fong Chou
Clinical and Vaccine Immunology, 2004
View PDFchevron_right
A Novel High-Throughput Single B-Cell Cloning Platform for Isolation and Characterization of High-Affinity and potent SARS-CoV-2 Neutralizing Antibodies
Paritosh Parashar
2022
View PDFchevron_right
Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2
Laura Villanueva
2020
View PDFchevron_right
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages
Aron Stålmarck
Nature Communications, 2023
View PDFchevron_right
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
toni delorey
Cell, 2021
View PDFchevron_right
Antibody responses to individual proteins of SARS coronavirus and their neutralization activities
Rongqiao He
Microbes and Infection, 2005
View PDFchevron_right
Impact of Host Immune Status on Discordant Anti-SARS-CoV-2 Circulating B Cell Frequencies and Antibody Levels
Jean-jacques Pin
International Journal of Molecular Sciences
View PDFchevron_right
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?
Youssouf Sereme
Stem cell reviews and reports, 2022
View PDFchevron_right
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
Marilia Cascalho
Scientific Reports
View PDFchevron_right
Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting
Kanwal Khalid
International Journal of Molecular Sciences
View PDFchevron_right
High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection
Anthony Kusalik
Scientific Reports, 2022
View PDFchevron_right
Immunodominant B cell epitope in a hotspot mutation site and mechanism of immune escape for SARS-CoV-2
Jamille Oliveira
2021
View PDFchevron_right
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
Rupert Beale
eLife
View PDFchevron_right
In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta)
Volker Fingerle
Microorganisms
View PDFchevron_right
Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
Te-Hui Chou
Virology, 2005
View PDFchevron_right
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors
Oren Zimhony
PLOS Pathogens, 2021
View PDFchevron_right
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
Yasushi Uematsu, Maria R Gismondo
Nature Medicine, 2004
View PDFchevron_right
Association of Naive B Cells with Humoral Response to SARS-CoV-2 Vaccination
Johannes Fessler
2021
View PDFchevron_right
A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG
Paola Bossu
Viruses
View PDFchevron_right
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Sirena Vargas
Nature Communications, 2021
View PDFchevron_right
Development of a Western Blot Assay for Detection of Antibodies against Coronavirus Causing Severe Acute Respiratory Syndrome
Hoorieh Soleimanjahi
Clinical and Vaccine Immunology, 2004
View PDFchevron_right
Development and Characterization of a Severe Acute Respiratory Syndromeassociated Coronavirusneutralizing Human Monoclonal Antibody That …
Jennifer Coccia
The Journal of …, 2005
View PDFchevron_right
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern
Gaukhar Yusubalieva
2021
View PDFchevron_right